Products of National Significance ANTIVENOMS & Q FEVER
Our aim is to support public health by providing medical solutions that help to protect the Australian population from potentially deadly bites, stings and infections.
CSL Seqirus has an agreement with the Australian Government leveraging our deep expertise to support Australia’s biosecurity strategy. This involves the onshore manufacture and supply of a unique range of products made in the national interest. The availability of these products maintains Australia’s high standards for responding to venomous bites and stings, and the prevention of infectious diseases that threaten the health and economy of our country. CSL Seqirus is the sole provider of the Q fever vaccine and Australian antivenoms for human use. We work in partnership with experts and organisations to educate the public and help to reduce the burden experienced by patients. Learn more below.
Q fever vaccine
CSL Seqirus is the world’s only manufacturer of Q fever vaccine for human use.2 We are committed to the prevention of this nationally notifiable disease through public education programs and strategies, working in partnership with healthcare professionals (HCPs), employer groups and other dedicated organisations to help reduce the burden of this disease.
Q Fever Facts - for the general public
Read stories from real patients who talk about the impact of Q fever and the challenges they faced when gaining a diagnosis whilst experiencing Q fever. Q fever Facts is an important online resource that can be easily shared to educate Australians about Q fever via a link, newsletters and social media channels.
Q Fever Facts - for healthcare professionals
This dedicated online resource for healthcare professionals has been developed with experts to support the education, diagnosis and management of Q fever. This resource aims to improve the understanding of who is at risk of contracting Q fever and how to implement preventative measures. Registration requires an AHPRA number and provides access to expert commentary, case studies, podcasts and downloadable education materials and clinic support materials to share with patients.
The ‘Making of Antivenoms’
CSL Seqirus, and our parent company CSL, has been pioneering antivenom solutions since the 1930s to meet a uniquely Australian challenge. As the only company in the world with the unique expertise to manufacture antivenoms onshore for Australia’s most venomous creatures, we work with partners to help protect Australians when they need it most.
Free smart phone app
CSL Seqirus has partnered with experts to provide information about snakes, spiders and marine creatures, and the latest first aid guidance for venomous bites and stings - Australian Bites & Stings: First Aid Guide to Australian Venomous Creatures.
Resource for Healthcare Professionals
This online resource for healthcare professionals has been created alongside experts to support education on venomous bites and stings and antivenom products. Simple registration requires an AHPRA number, for access to downloadable materials on venomous bites and stings management, and guidance on some common clinical questions.
Improving access to antivenom in Papua New Guinea
In Papua New Guinea (PNG), over 1,000 deaths from snakebite are estimated to occur annually, therefore the availability of antivenom is essential for timely emergency treatment5. CSL Seqirus has partnered with the PNG Government and industry to improve access to life-saving treatment with an annual donation of snake and marine creature antivenoms.
Collaborating to improve patient outcomes in Myanmar
Myanmar has one of the highest burdens of snakebite in the world6. CSL Seqirus has partnered with governments and industry to enhance the outcomes of snakebite patients by helping to improve antivenom production, availability and hospital care.
ANZ-AVAT-21-0016. Date of preparation: September 2022
- Australian Immunisation Handbook. Q fever [Updated 6 Jun 2018; Accessed 4 Jun 2021] https://immunisationhandbook.health.gov.au/vaccine-preventable-diseases/q-fever
- Armstrong M, Francis J, Robson J, et al. (2019) Q fever vaccination of children in Australia: Limited experience to date. Journal of Paediatrics and Child Health.
- Australian Institute of Health and Welfare. Venomous bites and stings, 2017–18. [Updated March 2021; Accessed 14 September 2021] https://www.aihw.gov.au/getmedia/78b416bf-0250-4368-89d6-81e2d9f32528/aihw-injcat-215.pdf.aspx
- Healy, J & Winkel, KD (Ed). Venom: Fear, fascination and discovery. Medical History Museum, University of Melbourne, 2013. Australia.
- PNG High Commission Snakebite Partnership Fact Sheet [Update 18 Oct 2018; Accessed 13 May 2021]
- Mahmood MA, Halliday D, Cumming R, Thwin K-T, Kyaw MMZ, White J, et al. (2018) Snakebite incidence in two townships in Mandalay Division, Myanmar. PLoS Negl Trop Dis 12(7): e0006643. https://doi.org/10.1371/journal.pntd.0006643